Literature DB >> 11802055

Compositional difference in middle ear effusion: mucous versus serous.

Myung-Hyun Chung1, Jae Young Choi, Won-Sang Lee, Hee-Nam Kim, Joo-Heon Yoon.   

Abstract

OBJECTIVES: Serous otitis media is usually responsive to medical treatment, whereas mucoid otitis media is not. The present study was undertaken to elucidate the compositional difference between serous and mucoid effusion and to investigate whether MUC5AC acts as a major mucin in the middle ear mucosa with mucoid otitis media. STUDY
DESIGN: This study involved a chemical analysis of middle ear effusion and immunostaining of the middle ear mucosa.
METHODS: Middle ear effusion samples were collected from 27 patients with mucoid otitis media and 18 patients with serous otitis media. The levels of mucin, lysozyme, secretory immunoglobulin A, and interleukin-8 were measured by dot blotting or enzyme-linked immunosorbent assay. Periodic acid-Schiff and immunohistochemical staining with monoclonal anti-MUC5AC antibody were performed on the serial sections of middle ear mucosa with mucoid otitis media.
RESULTS: Mucoid effusions contained higher levels of mucin, lysozyme, secretory immunoglobulin A, and interleukin-8 than did serous effusions. Immunohistological study revealed that MUC5AC mucin was expressed in only a small portion of the goblet cells of middle ear mucosa with mucoid otitis media.
CONCLUSIONS: The study suggests that both serous secretions and mucin might make the middle ear effusion more viscous and that mucins other than MUC5AC might have a major role in the viscosity of middle ear effusion. Further study is necessary to identify the major mucins in the middle ear effusion of otitis media with effusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802055     DOI: 10.1097/00005537-200201000-00027

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  18 in total

1.  MUC5B Is the predominant mucin glycoprotein in chronic otitis media fluid.

Authors:  Diego Preciado; Samita Goyal; Michael Rahimi; Alan M Watson; Kristy J Brown; Yetrib Hathout; Mary C Rose
Journal:  Pediatr Res       Date:  2010-09       Impact factor: 3.756

2.  The rationale for preventive treatments for early post-tympanostomy tube otorrhea in persistent otitis media with effusion.

Authors:  Mohammad Faramarzi; Sareh Roosta; Mahmood Shishegar; Rohollah Abbasi; Saeid Atighechi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-08       Impact factor: 2.503

Review 3.  Genetically engineered mucin mouse models for inflammation and cancer.

Authors:  Suhasini Joshi; Sushil Kumar; Sangeeta Bafna; Satyanarayana Rachagani; Kay-Uwe Wagner; Maneesh Jain; Surinder K Batra
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

4.  Differential diagnosis of otitis media with effusion using label-free Raman spectroscopy: A pilot study.

Authors:  Rishikesh Pandey; Chi Zhang; Jeon W Kang; Parind M Desai; Ramachandra R Dasari; Ishan Barman; Tulio A Valdez
Journal:  J Biophotonics       Date:  2018-01-17       Impact factor: 3.207

5.  Gel chromatographic characterization of proteins in mucous and serous middle ear effusions of patients with otitis media in comparison to serum proteins.

Authors:  Rie Yabe; Ryuzaburo Higo; Koichi Sugita; Masao Iwamori
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-09-22       Impact factor: 2.503

6.  Cigarette smoke activates NF kappa B and induces Muc5b expression in mouse middle ear cells.

Authors:  Diego Preciado; Jezhin Lin; Beverly Wuertz; Mary Rose
Journal:  Laryngoscope       Date:  2008-03       Impact factor: 3.325

Review 7.  Gastric pepsin in middle ear fluid of children with otitis media: clinical implications.

Authors:  Zhaoping He; Robert C O'Reilly; Devendra Mehta
Journal:  Curr Allergy Asthma Rep       Date:  2008-11       Impact factor: 4.806

8.  Cytokine levels in groups of patients with different duration of chronic secretory otitis.

Authors:  Svjetlana Matković; Danilo Vojvodić; Ivan Baljosevic
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-21       Impact factor: 2.503

9.  Non-invasive optical assessment of viscosity of middle ear effusions in otitis media.

Authors:  Guillermo L Monroy; Paritosh Pande; Ryan L Shelton; Ryan M Nolan; Darold R Spillman; Ryan G Porter; Michael A Novak; Stephen A Boppart
Journal:  J Biophotonics       Date:  2016-03-24       Impact factor: 3.207

10.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.